Ralph has 20+ years’ experience in the pharma industry, much of it as Head of Pharmacology at IRBM, the Rome site of Merck Research Laboratories. For his role in the discovery of IsentressTM, first-in-class inhibitor of HIV integrase and winner of the Prix Galien USA 2008 as best pharmaceutical agent, Ralph received the American Chemical Society Heroes of Chemistry Award 2013.
He joined Teva R&D from IRBM Science Park, a spin-off of MRL Rome. There, as Scientific Director, Ralph led the development of IRBM’s drug discovery strategy and pipeline of proprietary assets.
Ralph holds a PhD summa cum laude in Biochemistry from The Hebrew University of Jerusalem and undertook his postdoctoral training in the Changeux lab at the Institut Pasteur in Paris. He is the author of over 80 peer-reviewed articles and inventor on over 15 patents.